ETF PRO AIOctober 28, 2026
XPH SPDR S&P Pharmaceuticals ETF
Fund tearsheet · data as of the latest session · October 28, 2026
ONE YEAR OF DAILY CLOSES
0.35%expense ratio
$440Mfund assets
+14.2%return, YTD
+30.2%return, 1 year
−$80Mnet flow, 1 month
+$206Mnet flow, 1 year
23.6%realized volatility, 1y
-16.5%worst drawdown, 1y
Top ten holdings
| 1 | AMLX AMYLYX PHARMACEUTICALS | 2.04% |
| 2 | OMER OMEROS | 1.42% |
| 3 | MBX MBX Biosciences | 2.72% |
| 4 | DFTX Definium Therapeutics | 3.09% |
| 5 | PCRX PACIRA BIOSCIENCES | 1.65% |
| 6 | MANE VERADERMICS INC | 2.02% |
| 7 | PRGO PERRIGO CO | 1.42% |
| 8 | AMRX AMNEAL PHARMACEUTICALS | 1.72% |
| 9 | MAZE Maze Therapeutics | 1.85% |
| 10 | LGND LIGAND PHARMACEUTICALS | 1.94% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS